Blocking D2/D3 dopamine receptors increases volatility of beliefs when we learn to trust others

Nace Mikus,Christoph Eisenegger,Chris Mathys,Luke Clark,Ulrich Müller,Trevor W. Robbins,Claus Lamm,Michael Naef
DOI: https://doi.org/10.1101/2022.06.21.496956
2022-01-01
Abstract:The ability to flexibly adjust beliefs about other people is crucial for human social functioning. Dopamine has been proposed to regulate the precision of beliefs, but direct behavioural evidence of this is lacking. We investigated how a relatively high dose of the selective D2/D3 dopamine receptor antagonist sulpiride impacts learning about other people’s prosocial attitudes in a repeated trust game. Using a Bayesian model of belief updating, we show that sulpiride increased the volatility of beliefs, which led to higher precision-weights on prediction errors. This effect was entirely driven by participants with genetically conferring higher dopamine availability (Taq1a polymorphism). Higher precision weights were reflected in higher reciprocal behaviour in the repeated trust game but not in single-round trust games. This finding suggests that antipsychotic medication might acutely reduce rigidity of pathological beliefs. ### Competing Interest Statement LC has received royalties from Cambridge Cognition Ltd. relating to neurocognitive testing. UM discloses consultancy for Janssen-Cilag, Lilly, Heptares and Shire, and educational funding from AstraZeneca, Bristol-Myers Squibb, Janssen-Cilag, Lilly, Lundbeck and Pharmacia-Upjohn. TWR discloses consultancy with Cambridge Cognition Ltd and a research grant with Shionogi Inc. The remaining authors declare no conflict of interest.
What problem does this paper attempt to address?